Theseus Pharmaceuticals Appoints Steven Stein, M.D. to Board

/PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the...

Related Keywords

South Africa , United States , Johannesburg , Gauteng , Cambridge , Cambridgeshire , United Kingdom , Tim Clackson , Josh Rappaport , Steven Stein , Amy Jobe , Christen Baglaneas , Prnewswire Theseus Pharmaceuticals Inc , Nasdaq , Theseus Pharmaceuticals Inc , Exchange Commission , Theseus Pharmaceuticals , Lifesci Communications , Novartis Pharmaceuticals Corporation , University Of Pennsylvania , Head Of Medicines Development For Hematology , Department Of Medicine , Clinical Development , University Of Witwatersrand , Theseus Board , Chief Executive Officer , Executive Vice President , Chief Medical Officer , Senior Vice President , Medical Affairs , Vice President , Global Oncology , Medicines Development , Kura Oncology , Theseu Form , Quarterly Reports ,